Previous chapter:
Chapter 1849 - 1293: The Special Patient’s Speech
Next chapter:
Chapter 1851 - 1294: Miraculous Power
PREVIEW
... ns, the European Pharmaceutical Agency (EMA) conditionally accepted Ruixing’s data security framework plan. The key concession was allowing real-time synchronization of all EU patient treatment data between the main data center in China and the mirror center in Frankfurt.
The simultaneously established "Sino-European Medical Data Security Supervision Committee" will have dual veto rights—either party can suspend cross-border data flow if they believe data access may endanger patient priv ...
YOU MAY ALSO LIKE



























